Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017, Article ID 5469409, 5 pages
https://doi.org/10.1155/2017/5469409
Review Article

Inositol and In Vitro Fertilization with Embryo Transfer

Division of Obstetrics and Gynecology Oncology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Correspondence should be addressed to P. G. Artini; ti.ipinu.dem@initra.oloap

Received 7 July 2016; Accepted 13 October 2016; Published 28 February 2017

Academic Editor: Vittorio Unfer

Copyright © 2017 G. Simi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. G. Artini, V. Valentino, P. Monteleone et al., “Vascular endothelial growth factor level changes during human embryo development in culture medium,” Gynecological Endocrinology, vol. 24, no. 4, pp. 184–187, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. L. L. van Loendersloot, M. van Wely, J. Limpens, P. M. M. Bossuyt, S. Repping, and F. van der Veen, “Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis,” Human Reproduction Update, vol. 16, no. 6, pp. 577–589, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Ciotta, M. Stracquadanio, I. Pagano, A. Carbonaro, M. Palumbo, and F. Gulino, “Effects of myo-inositol supplementation on oocyte’s quality in PCOS patients: a double blind trial,” European Review for Medical and Pharmacological Sciences, vol. 15, no. 5, pp. 509–514, 2011. View at Google Scholar
  4. F. Lisi, P. Carfagna, M. M. Oliva et al., “Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study,” Reproductive Biology and Endocrinology, vol. 10, 52 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. F. A. Gulino, E. Leonardi, I. Marilli et al., “Effect of treatment with myo-inositol on semen parameters of patients undergoing an IVF cycle: in vivo study,” Gynecological Endocrinology, vol. 32, no. 1, pp. 65–68, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Benjamin, H. Nemetz, M. Fux, I. Bleichman, and G. Agam, “Acute inositol does not attenuate m-CPP-induced anxiety, mydriasis and endocrine effects in panic disorder,” Journal of Psychiatric Research, vol. 31, no. 4, pp. 489–495, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. L. C. Huang, M. C. Fonteles, D. B. Houston, C. Zhang, and J. Larner, “Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo,” Endocrinology, vol. 132, no. 2, pp. 652–657, 1993. View at Publisher · View at Google Scholar
  8. S. Akiba and T. Sato, “Cellular function of calcium-independent phospholipase A2,” Biological & Pharmaceutical Bulletin, vol. 27, no. 8, pp. 1174–1178, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. P. G. Artini, O. M. Di Berardino, F. Papini et al., “Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study,” Gynecological Endocrinology, vol. 29, no. 4, pp. 375–379, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. D. Smith, A. Mikkelsen, and S. Lindenberg, “Development of human oocytes matured in vitro for 28 or 36 hours,” Fertility and Sterility, vol. 73, no. 3, pp. 541–544, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Bizzarri, A. Cucina, S. Dinicola et al., “Does myo-inositol effect on PCOS follicles involve cytoskeleton regulation?” Medical Hypotheses, vol. 91, pp. 1–5, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Bevilacqua and M. Bizzarri, “Physiological role and clinical utility of inositols in polycystic ovary syndrome,” Best Practice & Research Clinical Obstetrics & Gynaecology, vol. 37, pp. 129–139, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Carlomagno, V. Unfer, and S. Roseff, “The D-chiro-inositol paradox in the ovary,” Fertility and Sterility, vol. 95, no. 8, pp. 2515–2516, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. S. Laganà, P. Rossetti, M. Buscema et al., “Metabolism and ovarian function in pcos women: a therapeutic approach with inositols,” International Journal of Endocrinology, vol. 2016, Article ID 6306410, 9 pages, 2016. View at Publisher · View at Google Scholar
  15. R. Isabella and E. Raffone, “Does ovary need D-chiro-inositol?” Journal of Ovarian Research, vol. 5, no. 1, 14 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Papaleo, V. Unfer, J.-P. Baillargeon, F. Fusi, F. Occhi, and L. De Santis, “Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial,” Fertility and Sterility, vol. 91, no. 5, pp. 1750–1754, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Unfer, E. Raffone, P. Rizzo, and S. Buffo, “Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study,” Gynecological Endocrinology, vol. 27, no. 11, pp. 857–861, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Rizzo, E. Raffone, and V. Benedetto, “Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial,” European Review for Medical and Pharmacological Sciences, vol. 14, no. 6, pp. 555–561, 2010. View at Google Scholar
  19. T. T. Y. Chiu, M. S. Rogers, E. L. K. Law, C. M. Briton-Jones, L. P. Cheung, and C. J. Haines, “Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality,” Human Reproduction (Oxford, England), vol. 17, no. 6, pp. 1591–1596, 2002. View at Publisher · View at Google Scholar
  20. R. Homburg, “Polycystic ovary syndrome—from gynaecological curiosity to multisystem endocrinopathy,” Human Reproduction (Oxford, England), vol. 11, no. 1, pp. 29–39, 1996. View at Publisher · View at Google Scholar
  21. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group, “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS),” Human Reproduction (Oxford, England), vol. 19, no. 1, pp. 41–47, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. A. D. Genazzani, C. Lanzoni, F. Ricchieri, E. Baraldi, E. Casarosa, and V. M. Jasonni, “Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia,” Gynecological Endocrinology, vol. 23, no. 3, pp. 146–152, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Pizzo, A. S. Laganà, and L. Barbaro, “Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS,” Gynecological Endocrinology, vol. 30, no. 3, pp. 205–208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. J. E. Nestler, D. J. Jakubowicz, P. Reamer, R. D. Gunn, and G. Allan, “Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome,” The New England Journal of Medicine, vol. 340, no. 17, pp. 1314–1320, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. M. J. Iuorno, D. J. Jakubowicz, J. P. Baillargeon et al., “Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome,” Endocrine Practice, vol. 8, no. 6, pp. 417–423, 2002. View at Publisher · View at Google Scholar
  26. S. Gerli, E. Papaleo, A. Ferrari, and G. C. Di Renzo, “Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS,” European Review for Medical and Pharmacological Sciences, vol. 11, no. 5, pp. 347–354, 2007. View at Google Scholar
  27. M. Minozzi, D. Costantino, C. Guaraldi, and V. Unfer, “The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome,” Gynecological Endocrinology, vol. 27, no. 11, pp. 920–924, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Unfer, G. Carlomagno, P. Rizzo, E. Raffone, and S. Roseff, “Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial,” European Review for Medical and Pharmacological Sciences, vol. 15, no. 4, pp. 452–457, 2011. View at Google Scholar
  29. S. Colazingari, M. Treglia, R. Najjar, and A. Bevilacqua, “The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial,” Archives of Gynecology and Obstetrics, vol. 288, no. 6, pp. 1405–1411, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Pacchiarotti, G. Carlomagno, G. Antonini, and A. Pacchiarotti, “Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome,” Gynecological Endocrinology, vol. 32, no. 1, pp. 69–73, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Aboulghar, “Symposium: update on prediction and management of OHSS. Prevention of OHSS,” Reproductive Biomedicine Online, vol. 19, no. 1, pp. 33–42, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. G. A. Turan, F. Eskicioglu, O. N. Sivrikoz et al., “Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study,” Archives of Gynecology and Obstetrics, vol. 292, no. 5, pp. 1163–1171, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. A. P. Ferraretti, A. La Marca, B. C. J. M. Fauser, B. Tarlatzis, G. Nargund, and L. Gianaroli, “ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria,” Human Reproduction (Oxford, England), vol. 26, no. 7, pp. 1616–1624, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Caprio, M. D. D’Eufemia, C. Trotta et al., “Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial,” Journal of Ovarian Research, vol. 8, 37 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. T. R. Chauvin and M. D. Griswold, “Characterization of the expression and regulation of genes necessary for myo-inositol biosynthesis and transport in the seminiferous epithelium,” Biology of Reproduction, vol. 70, no. 3, pp. 744–751, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. B. T. Hinton, R. W. White, and B. P. Setchell, “Concentrations of myo-inositol in the luminal fluid of the mammalian testis and epididymis,” Journal of Reproduction and Fertility, vol. 58, no. 2, pp. 395–399, 1980. View at Publisher · View at Google Scholar
  37. M. Colone, G. Marelli, V. Unfer, G. Bozzuto, A. Molinari, and A. Stringaro, “Inositol activity in oligoasthenoteratospermia—an in vitro study,” European Review for Medical and Pharmacological Sciences, vol. 14, no. 10, pp. 891–896, 2010. View at Google Scholar
  38. D. Y. Liu, G. N. Clarke, and H. W. G. Baker, “Hyper-osmotic condition enhances protein tyrosine phosphorylation and zona pellucida binding capacity of human sperm,” Human Reproduction (Oxford, England), vol. 21, no. 3, pp. 745–752, 2006. View at Publisher · View at Google Scholar · View at Scopus